IceCure Medical Ltd
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Net Income | $-15.1M | $-15.3M | $-14.7M | $-17.0M | $-9.9M | $-3.7M | $-4.6M |
| Depreciation & Amortization | — | — | — | — | — | — | — |
| Depreciation | $295.0K | $332.0K | $323.0K | $248.0K | $127.0K | $63.0K | $32.0K |
| Amortization | — | — | — | — | — | — | — |
| Stock-Based Compensation | $1.4M | $869.0K | $1.3M | $1.9M | $316.0K | $229.0K | $372.0K |
| Net Cash from Operating Activities | $-14.6M | $-12.6M | $-12.6M | $-14.3M | $-12.6M | $-3.7M | $-2.0M |
| Investing Activities | |||||||
| Capital Expenditures | $36.0K | $71.0K | $480.0K | $891.0K | $533.0K | $223.0K | $103.0K |
| Business Acquisitions | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-36.0K | $446.0K | $-684.0K | $-891.0K | $3.8M | $-4.7M | $-103.0K |
| Financing Activities | |||||||
| Dividends Paid | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $15.8M | $9.2M | $83.0K | $13.6M | $30.9M | $5.9M | $3.3M |
| Net Change in Cash | — | — | — | $-1.6M | $22.1M | $-2.5M | $1.2M |
| Free Cash Flow | $-14.6M | $-12.6M | $-13.0M | $-15.2M | $-13.1M | $-3.9M | $-2.1M |